MargaretBlockMD

Oncology • Omaha, NE

Breast Cancer, Hematologic Oncology

Physician

Join to view full profile

Dr. Block is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Block's full profile

Already have an account?

Office
17201 Wright St
Omaha, NE 68130
Phone+1 402-334-4773

Fax+1 402-330-7463
Is this information wrong?

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1980 - 1981
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1980
Rush University Medical CenterResidency, Internal Medicine, 1976 - 1979
Albany Medical CollegeClass of 1976

Certifications & Licensure

WI State Medical License 1980 - 2025
IA State Medical License 1989 - 2024
NE State Medical License 1989 - 2024
IL State Medical License 1977 - 1993
PA State Medical License 1983 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer Start of enrollment: 2012 Apr 01
Terminated
Phase 2
Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index Start of enrollment: 2013 Apr 01
Completed
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer Start of enrollment: 2014 Jul 22
Active, not recruiting
Phase 3
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib Start of enrollment: 2017 Jun 07
Terminated
Phase 3
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer Start of enrollment: 2020 Dec 01
Active, not recruiting
Phase 2
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer Start of enrollment: 2022 Mar 07
Recruiting
Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

2 citations
Reply to T. Shimoi et al and Y. Shimanuki et al.
Ingrid A. Mayer, Fengmin Zhao, Carlos L. Arteaga, William Fraser Symmans, Ben Ho Park, Brian L. Burnette, Amye J. Tevaarwerk, Sofia F. Garcia, Karen L. Smith, Della F....> ;Journal of Clinical Oncology. 2021 Sep 23
9 citations
Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when adde...
Volkmar Mueller, Andrew M Wardley, Elisavet Paplomata, Erika Hamilton, Amelia Zelnak, Louis Fehrenbacher, Erik Jakobsen, Elsa Curtit, Frances M. Boyle, Eva Harder Brix...> ;European Journal of Cancer. 2021 Jun 29
12 citations
Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients.
, , , , , , , , , , , , , , , , , > ;NPJ Breast Cancer. 2021 Jun 11
64 citations
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuva...
Ingrid A. Mayer, Fengmin Zhao, Carlos L. Arteaga, William Fraser Symmans, Ben Ho Park, Brian L. Burnette, Amye J. Tevaarwerk, Sofia F. Garcia, Karen L. Smith, Della F....> ;Journal of Clinical Oncology. 2021 Jun 6
17 citations
Efficacy and Safety of Weekly Paclitaxel With or Without Oral Alisertib in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial.
Joyce O'Shaughnessy, Kristi McIntyre, Sharon Wilks, Ling Ma, Margaret Block, David Andorsky, Michael A. Danso, Tracy Locke, Amy Scales, Yunfei Wang> ;JAMA Network Open. 2021 Apr 1
19 citations
Use of the blood substitute HBOC‐201 in critically ill patients during sickle crisis: a three‐case series
Jonathan M. Davis, Nura El-Haj, Nimish Shah, Garry Schwartz, Margaret Block, James Wall, Mark Tidswell, Ernest DiNino> ;Transfusion. 2018 Jan 1
24 citations
Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group.
Aminah Jatoi, Steven R. Alberts, Nathan R. Foster, Roscoe F. Morton, Patrick A. Burch, Margaret Block, Phuong L. Nguyen, John W. Kugler> ;Supportive Care in Cancer. 2005 Mar 10
16 citations
A phase II study of topical ceramides for cutaneous breast cancer.
Aminah Jatoi, Vera J. Suman, Paul L. Schaefer, Margaret Block, Charles L. Loprinzi, Patrick C. Roche, Stuart Garneau, Roscoe F. Morton, Philip J. Stella, Steven R. Alb...> ;Breast Cancer Research and Treatment. 2003 Jul 1
24 citations
Phase III Evaluation of Octreotide versus Chemotherapy with 5-Fluorouracil or 5-Fluorouracil Plus Leucovorin in Advanced Exocrine Pancreatic Cancer: A North Central Ca...
Patrick A. Burch, Margaret Block, Georgene Schroeder, John W. Kugler, Daniel J. Sargent, Theodore A. Braich, James A. Mailliard, John C. Michalak, A K Hatfield, Keith ...> ;Clinical Cancer Research. 2000 Sep 1
3 citations
Pulmonary fibrosis associated with low-dose adjuvant methyl-CCNU
Margaret Block, Robert M. Lachowiez, Carlos Rios, Simon Hirschl> ;Medical and Pediatric Oncology. 1990 Jan 1
13 citations
Metastatic neuroblastoma arising in an ovarian teratoma with long-term survival. Case report and review of the literature.
Margaret Block, Enid F. Gilbert, Carleton Davis> ;Cancer. 1984 Aug 1
24 citations
Radiation carcinogenesis in man: new primary neoplasms in fields of prior therapeutic radiation.
A. M. Sadove, M. Block, Arthur H. Rossof, A. Doolas, Steven G. Economou, Jules E. Harris, Harry W. Southwick, Frank R. Hendrickson, J Wolter> ;Cancer. 1981 Sep 1
14 citations
Nonchromaffin paraganglioma. Report of a Case
Malcolm B. Dockerty, John M. Waugh> ;Cancer. 1955 Jan 1
Join now to see all

Hospital Affiliations

CHI Health Creighton University Medical Center - Bergan MercyOmaha, Nebraska
CHI Health ImmanuelOmaha, Nebraska
CHI Health Creighton University Medical CenterOmaha, Nebraska
Nebraska Methodist HospitalOmaha, Nebraska
Methodist Fremont HealthFremont, Nebraska